Waterland exits Zentrum Gesundheit to Nord in SBO

The group's medical practitioners and managers will remain shareholders in the group following the deal.

The company's revenues grew from €15m in 2017 to €18m in 2018, and it added seven new sites. It generates around €7m in EBITDA.

This announcement follows Waterland's launch of sale processes for rehabilitation clinics group Median Kliniken and fertility clinics group VivaNeo.

Nord acts as an evergreen fund, investing from its own balance sheet with no maturity restrictions. Currently, the fund has interests in more than 15 companies in the DACH region.

Previous funding
Waterland acquired a majority stake in the group in 2017 with plans to maintain its growth through regional and portfolio expansion.

Company
Zentrum is a group of outpatient ophthalmic surgery and diagnostic centres in Lower Saxony and Bremen. It employs more than 230 staff members, the majority of whom are medical practitioners or specialist medical assistants. Its medical services focus on outpatient treatment and surgery for patients with cataracts, glaucoma, and diabetic and age-related retinal diseases. The company was founded in 1990 and now has nine centres.

People
Waterland Private Equity – Carsten Rahlfs (managing partner).
Zentrum Gesundheit – Dieter Hagedorn (managing partner).

Advisers
Vendor – Quarton International (corporate finance).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Buyouts
• DACH
• Healthcare
• Germany
• healthcare
• Waterland Private Equity
• Secondary buyout
• Nord Holding